NPC was little studied in the past because of its rarity; NPC1 is diagnosed in one in every 92,000–150,000 births, though recent genome and exome analysis including late appearing phenotypes predicts an increased incidence of one in 20,000–39,000 births [15]. Here, NPC1 is linked to nasopharyngeal carcinoma.